- Home
- BCYC vs FOR Comparison
BCYC vs FOR Comparison
Compare BCYC & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- FOR
- Stock Information
- Founded
- BCYC 2009
- FOR 2005
- Country
- BCYC United Kingdom
- FOR United States
- Employees
- BCYC N/A
- FOR N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- FOR Real Estate
- Sector
- BCYC Health Care
- FOR Finance
- Exchange
- BCYC Nasdaq
- FOR Nasdaq
- Market Cap
- BCYC 1.7B
- FOR 1.4B
- IPO Year
- BCYC 2019
- FOR 2007
- Fundamental
- Price
- BCYC $13.34
- FOR $26.79
- Analyst Decision
- BCYC Buy
- FOR Strong Buy
- Analyst Count
- BCYC 9
- FOR 4
- Target Price
- BCYC $34.50
- FOR $39.25
- AVG Volume (30 Days)
- BCYC 417.9K
- FOR 151.0K
- Earning Date
- BCYC 02-18-2025
- FOR 01-21-2025
- Dividend Yield
- BCYC N/A
- FOR N/A
- EPS Growth
- BCYC N/A
- FOR 20.12
- EPS
- BCYC N/A
- FOR 4.00
- Revenue
- BCYC $36,898,000.00
- FOR $1,509,400,000.00
- Revenue This Year
- BCYC $40.69
- FOR $9.38
- Revenue Next Year
- BCYC N/A
- FOR $11.69
- P/E Ratio
- BCYC N/A
- FOR $6.70
- Revenue Growth
- BCYC 48.60
- FOR 5.05
- 52 Week Low
- BCYC $12.17
- FOR $24.81
- 52 Week High
- BCYC $28.67
- FOR $40.92
- Technical
- Relative Strength Index (RSI)
- BCYC 34.88
- FOR 50.09
- Support Level
- BCYC $13.20
- FOR $24.81
- Resistance Level
- BCYC $15.43
- FOR $26.61
- Average True Range (ATR)
- BCYC 0.89
- FOR 0.69
- MACD
- BCYC 0.16
- FOR 0.31
- Stochastic Oscillator
- BCYC 6.17
- FOR 67.35
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
About FOR Forestar Group Inc
Forestar Group Inc is a residential lot development company with operations across the United States. The core business segment for the company is real estate which generates all of it's revenues. The firm fundamentally acquires entitled real estate and develops it into finished residential lots for sale to homebuilders with a strategic focus on asset turns and efficiency. Single-family residential communities account for the majority of their real estate projects. The company utilizes a lower-risk business model mainly by investing in short duration, phased development projects.